title: Best practice in primary care pathology: review 10.
abstract: This tenth best practice review examines four series of common primary care questions in laboratory medicine: (i) antenatal testing in pregnant women; (ii) estimated glomerular filtration rate calculation; (iii) safety testing for methotrexate; and (iv) blood glucose measurement in diabetes. The review is presented in question-answer format, referenced for each question series. The recommendations represent a precis of guidance found using a standardised literature search of national and international guidance notes, consensus statements, health policy documents and evidence-based medicine reviews, supplemented by Medline Embase searches to identify relevant primary research documents. They are not standards but form a guide to be set in the clinical context. Most are consensus rather than evidence-based. They will be updated periodically to take account of new information.
authors.affiliation: Department of Chemical Pathology, Bishop Auckland General Hospital, Bishop Auckland, UK. info@smellie.com
authors.forename: W S A
authors.initials: WS
authors.lastname: Smellie
authors.forename: N
authors.initials: N
authors.lastname: Shaw
authors.forename: R
authors.initials: R
authors.lastname: Bowley
authors.forename: M F
authors.initials: MF
authors.lastname: Stewart
authors.forename: A M
authors.initials: AM
authors.lastname: Kelly
authors.forename: P J
authors.initials: PJ
authors.lastname: Twomey
authors.forename: P R
authors.initials: PR
authors.lastname: Chadwick
authors.forename: J B
authors.initials: JB
authors.lastname: Houghton
authors.forename: J P
authors.initials: JP
authors.lastname: Ng
authors.forename: A J
authors.initials: AJ
authors.lastname: McCulloch
mesh_terms: D001786:Blood Glucose / Q000032:analysis; D003924:Diabetes Mellitus, Type 2 / Q000175:diagnosis*; D016903:Drug Monitoring / Q000379:methods*; D005260:Female; D005919:Glomerular Filtration Rate; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects; D008727:Methotrexate / Q000009:adverse effects; D018579:Patient Selection; D011247:Pregnancy; D011295:Prenatal Care / Q000379:methods*; D011320:Primary Health Care / Q000379:methods*
chemical_list: D001786:Blood Glucose; D007166:Immunosuppressive Agents; D008727:Methotrexate